The global AI in breast imaging market size was valued at USD 305.9 million in 2025 and is projected to grow from USD 391.9 million in 2026 to USD 1.82 billion by 2033, at a CAGR of 24.6% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.1% in 2025. The industry is driven by the increasing adoption of AI-assisted breast cancer screening and diagnosis, along with rising breast cancer incidence and screening volumes. Growing demand for radiologist workflow support and the expanding use of AI for cancer detection, breast density assessment, risk prediction, and diagnostic decision support are also driving the market.
AI-based solutions are being applied across mammography, digital breast tomosynthesis, breast ultrasound, and breast MRI for cancer detection and localization, lesion characterization, breast density assessment, risk prediction, image reconstruction, and workflow support. Recent clinical evidence is expanding the potential role of AI beyond basic detection. In July 2026, a study published in Radiology evaluated more than 577,000 screening mammograms across 109 U.S. imaging sites and found that integration of DeepHealth's AI-powered workflow increased the adjusted cancer detection rate among general radiologists by 32.7%, from 3.76 to 4.99 cancers per 1,000 examinations, reaching a level comparable to breast imaging specialists using the same workflow. AI applications are also expanding toward long-term risk assessment.
In September 2026, a study evaluated the IICM+ AI model for predicting distant breast cancer recurrence in patients with early-stage HR+/HER2-negative, node-negative disease. The model achieved a C-index of 0.735 compared with 0.578 for the 21-gene Recurrence Score in a separate validation group, although additional validation across larger and more diverse populations is required before routine clinical use. These developments are broadening the addressable application landscape toward cancer detection, diagnostic decision support, image-based risk prediction, and treatment monitoring. Regulatory clearances, clinical validation, digital imaging infrastructure, cloud-based deployment, and partnerships between AI developers and healthcare providers are further supporting market expansion.
AI-based solutions are being applied across mammography, digital breast tomosynthesis, breast ultrasound, and breast MRI for cancer detection and localization, lesion characterization, breast density assessment, risk prediction, image reconstruction, and workflow support. Recent clinical evidence is expanding the potential role of AI beyond basic detection. In July 2026, a study published in Radiology evaluated more than 577,000 screening mammograms across 109 U.S. imaging sites and found that integration of DeepHealth's AI-powered workflow increased the adjusted cancer detection rate among general radiologists by 32.7%, from 3.76 to 4.99 cancers per 1,000 examinations, reaching a level comparable to breast imaging specialists using the same workflow. AI applications are also expanding toward long-term risk assessment.
In September 2026, a study evaluated the IICM+ AI model for predicting distant breast cancer recurrence in patients with early-stage HR+/HER2-negative, node-negative disease. The model achieved a C-index of 0.735 compared with 0.578 for the 21-gene Recurrence Score in a separate validation group, although additional validation across larger and more diverse populations is required before routine clinical use. These developments are broadening the addressable application landscape toward cancer detection, diagnostic decision support, image-based risk prediction, and treatment monitoring. Regulatory clearances, clinical validation, digital imaging infrastructure, cloud-based deployment, and partnerships between AI developers and healthcare providers are further supporting market expansion.
Global AI in Breast Imaging Market Report Segmentation
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest industry trends & opportunities in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented global AI in breast imaging market report based on imaging modality, application, clinical use, end use, deployment, and region:Imaging Modality Outlook (Revenue, USD Million, 2021 - 2033)
- Mammography
- 2D Digital Mammography
- Digital Breast Tomosynthesis
- Contrast-Enhanced Mammography
- Breast Ultrasound
- Handheld Ultrasound
- Automated Whole-Breast Ultrasound
- Breast MRI
- Conventional Contrast-Enhanced MRI
- Abbreviated Breast MRI
- Other Imaging Modalities
Application Outlook (Revenue, USD Million, 2021 - 2033)
- Cancer Detection and Localization
- Lesion Characterization and Diagnostic Support
- Breast Density Assessment
- Image-Based Risk Prediction
- Image Acquisition and Reconstruction
- Workflow, Reporting, and Quality Assurance
- Treatment Response Assessment
Clinical Use Outlook (Revenue, USD Million, 2021 - 2033)
- Routine Screening
- Supplemental and High-Risk Screening
- Diagnostic Evaluation
- Staging and Treatment Monitoring
End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals & Academic Medical Centers
- Independent Breast and Women’s Health Centers
- Independent Diagnostic Imaging Centers
- Government & Public Health Screening Programs
Deployment Outlook (Revenue, USD Million, 2021 - 2033)
- On-Premise
- Cloud-Based
- Hybrid
Regional Outlook (Revenue, USD Million, 2021-2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Thailand
- Australia
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Imaging Modality
1.1.2. Application
1.1.3. Clinical Use
1.1.4. End Use
1.1.5. Deployment
1.1.6. Regional scope
1.1.7. Estimates and forecast timeline
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. The internal database
1.5. Details of primary research
1.5.1. Data for primary interviews in North America
1.5.2. Data for primary interviews in Europe
1.5.3. Data for primary interviews in Asia Pacific
1.5.4. Data for primary interviews in Latin America
1.5.5. Data for Primary interviews in MEA
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.1.1. Approach 1: Commodity flow approach
1.7.2. Volume price analysis (Model 2)
1.7.2.1. Approach 2: Volume price analysis
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
1.1.1. Imaging Modality
1.1.2. Application
1.1.3. Clinical Use
1.1.4. End Use
1.1.5. Deployment
1.1.6. Regional scope
1.1.7. Estimates and forecast timeline
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. The internal database
1.5. Details of primary research
1.5.1. Data for primary interviews in North America
1.5.2. Data for primary interviews in Europe
1.5.3. Data for primary interviews in Asia Pacific
1.5.4. Data for primary interviews in Latin America
1.5.5. Data for Primary interviews in MEA
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.1.1. Approach 1: Commodity flow approach
1.7.2. Volume price analysis (Model 2)
1.7.2.1. Approach 2: Volume price analysis
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. AI in Breast Imaging Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Increasing breast cancer screening volumes and earlier screening initiation
3.2.1.2. Clinical evidence supporting AI-assisted mammography
3.2.1.3. Growing demand for radiologist workload reduction
3.2.1.4. Increasing adoption of AI-based breast density assessment
3.2.2. Market Restraints Analysis
3.2.2.1. Insufficient evidence for several supplemental screening applications
3.2.2.2. Concerns regarding false positives, accountability, workflow integration, and implementation costs
3.2.3. Market Opportunity Analysis
3.2.3.1. Expansion of AI-based breast cancer risk prediction
3.2.3.2. AI-enabled breast density assessment and supplemental screening decision support
3.2.3.3. Expansion from mammography into multimodality breast imaging
3.2.3.4. Development of AI platforms supporting the complete breast-imaging workflow
3.2.4. Market Challenge Analysis
3.2.4.1. Regulatory, interoperability, cybersecurity, and clinical accountability requirements
3.2.4.2. Balancing higher cancer detection with false-positive and recall management
3.3. AI in Breast Imaging Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal landscape
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Increasing breast cancer screening volumes and earlier screening initiation
3.2.1.2. Clinical evidence supporting AI-assisted mammography
3.2.1.3. Growing demand for radiologist workload reduction
3.2.1.4. Increasing adoption of AI-based breast density assessment
3.2.2. Market Restraints Analysis
3.2.2.1. Insufficient evidence for several supplemental screening applications
3.2.2.2. Concerns regarding false positives, accountability, workflow integration, and implementation costs
3.2.3. Market Opportunity Analysis
3.2.3.1. Expansion of AI-based breast cancer risk prediction
3.2.3.2. AI-enabled breast density assessment and supplemental screening decision support
3.2.3.3. Expansion from mammography into multimodality breast imaging
3.2.3.4. Development of AI platforms supporting the complete breast-imaging workflow
3.2.4. Market Challenge Analysis
3.2.4.1. Regulatory, interoperability, cybersecurity, and clinical accountability requirements
3.2.4.2. Balancing higher cancer detection with false-positive and recall management
3.3. AI in Breast Imaging Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal landscape
Chapter 4. AI in Breast Imaging Market: Imaging Modality Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global AI in Breast Imaging Market: Imaging Modality Movement Analysis, 2025 & 2033 (USD Million)
4.3. Global AI in Breast Imaging Market Size & Trend Analysis, Imaging Modality, 2021 to 2033 (USD Million)
4.4. Mammography
4.4.1. Mammography market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.4.2. 2D Digital Mammography
4.4.2.1. 2D digital mammography market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.4.3. Digital Breast Tomosynthesis
4.4.3.1. Digital breast tomosynthesis market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.4.4. Contrast-Enhanced Mammography
4.4.4.1. Contrast-enhanced mammography market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.5. Breast Ultrasound
4.5.1. Breast ultrasound market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.5.2. Handheld Ultrasound
4.5.2.1. Handheld ultrasound market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.5.3. Automated Whole-Breast Ultrasound
4.5.3.1. Automated whole-breast ultrasound market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.6. Breast MRI
4.6.1. Breast MRI market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.6.2. Conventional Contrast-Enhanced MRI
4.6.2.1. Conventional contrast-enhanced MRI market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.6.3. Abbreviated Breast MRI
4.6.3.1. Abbreviated breast MRI market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.7. Other Imaging Modalities
4.7.1. Other imaging modalities market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.2. Global AI in Breast Imaging Market: Imaging Modality Movement Analysis, 2025 & 2033 (USD Million)
4.3. Global AI in Breast Imaging Market Size & Trend Analysis, Imaging Modality, 2021 to 2033 (USD Million)
4.4. Mammography
4.4.1. Mammography market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.4.2. 2D Digital Mammography
4.4.2.1. 2D digital mammography market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.4.3. Digital Breast Tomosynthesis
4.4.3.1. Digital breast tomosynthesis market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.4.4. Contrast-Enhanced Mammography
4.4.4.1. Contrast-enhanced mammography market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.5. Breast Ultrasound
4.5.1. Breast ultrasound market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.5.2. Handheld Ultrasound
4.5.2.1. Handheld ultrasound market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.5.3. Automated Whole-Breast Ultrasound
4.5.3.1. Automated whole-breast ultrasound market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.6. Breast MRI
4.6.1. Breast MRI market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.6.2. Conventional Contrast-Enhanced MRI
4.6.2.1. Conventional contrast-enhanced MRI market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.6.3. Abbreviated Breast MRI
4.6.3.1. Abbreviated breast MRI market revenue estimates and forecasts, 2021 - 2033 (USD Million)
4.7. Other Imaging Modalities
4.7.1. Other imaging modalities market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 5. AI in Breast Imaging Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global AI in Breast Imaging Market: Application Movement Analysis, 2025 & 2033 (USD Million)
5.3. Global AI in Breast Imaging Market Size & Trend Analysis, Application 2021 to 2033 (USD Million)
5.4. Cancer Detection and Localization
5.4.1. Cancer detection and localization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.5. Lesion Characterization and Diagnostic Support
5.5.1. Lesion characterization and diagnostic support market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.6. Breast Density Assessment
5.6.1. Breast density assessment market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.7. Image-Based Risk Prediction
5.7.1. Image-based risk prediction market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.8. Image Acquisition and Reconstruction
5.8.1. Image acquisition and reconstruction market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.9. Workflow, Reporting, and Quality Assurance
5.9.1. Workflow, reporting, and quality assurance market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.10. Treatment Response Assessment
5.10.1. Treatment response assessment market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.2. Global AI in Breast Imaging Market: Application Movement Analysis, 2025 & 2033 (USD Million)
5.3. Global AI in Breast Imaging Market Size & Trend Analysis, Application 2021 to 2033 (USD Million)
5.4. Cancer Detection and Localization
5.4.1. Cancer detection and localization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.5. Lesion Characterization and Diagnostic Support
5.5.1. Lesion characterization and diagnostic support market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.6. Breast Density Assessment
5.6.1. Breast density assessment market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.7. Image-Based Risk Prediction
5.7.1. Image-based risk prediction market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.8. Image Acquisition and Reconstruction
5.8.1. Image acquisition and reconstruction market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.9. Workflow, Reporting, and Quality Assurance
5.9.1. Workflow, reporting, and quality assurance market revenue estimates and forecasts, 2021 - 2033 (USD Million)
5.10. Treatment Response Assessment
5.10.1. Treatment response assessment market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 6. AI in Breast Imaging Market: Clinical Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global AI in Breast Imaging Market: Clinical Use Movement Analysis, 2025 & 2033 (USD Million)
6.3. Global AI in Breast Imaging Market Size & Trend Analysis, Clinical Use 2021 to 2033 (USD Million)
6.4. Routine Screening
6.4.1. Routine screening market revenue estimates and forecasts, 2021 - 2033 (USD Million)
6.5. Supplemental and High-Risk Screening
6.5.1. Supplemental and high-risk screening market revenue estimates and forecasts, 2021 - 2033 (USD Million)
6.6. Diagnostic Evaluation
6.6.1. Diagnostic evaluation market revenue estimates and forecasts, 2021 - 2033 (USD Million)
6.7. Staging and Treatment Monitoring
6.7.1. Staging and treatment monitoring market revenue estimates and forecasts, 2021 - 2033 (USD Million)
6.2. Global AI in Breast Imaging Market: Clinical Use Movement Analysis, 2025 & 2033 (USD Million)
6.3. Global AI in Breast Imaging Market Size & Trend Analysis, Clinical Use 2021 to 2033 (USD Million)
6.4. Routine Screening
6.4.1. Routine screening market revenue estimates and forecasts, 2021 - 2033 (USD Million)
6.5. Supplemental and High-Risk Screening
6.5.1. Supplemental and high-risk screening market revenue estimates and forecasts, 2021 - 2033 (USD Million)
6.6. Diagnostic Evaluation
6.6.1. Diagnostic evaluation market revenue estimates and forecasts, 2021 - 2033 (USD Million)
6.7. Staging and Treatment Monitoring
6.7.1. Staging and treatment monitoring market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 7. AI in Breast Imaging Market: End-Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global AI in Breast Imaging Market: End-Use Movement Analysis, 2025 & 2033 (USD Million)
7.3. Global AI in Breast Imaging Market Size & Trend Analysis, End-Use, 2021 to 2033 (USD Million)
7.4. Hospitals & Academic Medical Centers
7.4.1. Hospitals & academic medical centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
7.5. Independent Breast and Women’s Health Centers
7.5.1. Independent breast and women’s health centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
7.6. Independent Diagnostic Imaging Centers
7.6.1. Independent diagnostic imaging centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
7.7. Government & Public Health Screening Programs
7.7.1. Government & public health screening programs market revenue estimates and forecasts, 2021 - 2033 (USD Million)
7.2. Global AI in Breast Imaging Market: End-Use Movement Analysis, 2025 & 2033 (USD Million)
7.3. Global AI in Breast Imaging Market Size & Trend Analysis, End-Use, 2021 to 2033 (USD Million)
7.4. Hospitals & Academic Medical Centers
7.4.1. Hospitals & academic medical centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
7.5. Independent Breast and Women’s Health Centers
7.5.1. Independent breast and women’s health centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
7.6. Independent Diagnostic Imaging Centers
7.6.1. Independent diagnostic imaging centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
7.7. Government & Public Health Screening Programs
7.7.1. Government & public health screening programs market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 8. AI in Breast Imaging Market: Deployment Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Global AI in Breast Imaging Market: Deployment Movement Analysis, 2025 & 2033 (USD Million)
8.3. Global AI in Breast Imaging Market Size & Trend Analysis, Deployment 2021 to 2033 (USD Million)
8.4. On-Premise
8.4.1. On-premises market revenue estimates and forecasts, 2021 - 2033 (USD Million)
8.5. Cloud-Based
8.5.1. Cloud-based market revenue estimates and forecasts, 2021 - 2033 (USD Million)
8.6. Hybrid
8.6.1. Hybrid market revenue estimates and forecasts, 2021 - 2033 (USD Million)
8.2. Global AI in Breast Imaging Market: Deployment Movement Analysis, 2025 & 2033 (USD Million)
8.3. Global AI in Breast Imaging Market Size & Trend Analysis, Deployment 2021 to 2033 (USD Million)
8.4. On-Premise
8.4.1. On-premises market revenue estimates and forecasts, 2021 - 2033 (USD Million)
8.5. Cloud-Based
8.5.1. Cloud-based market revenue estimates and forecasts, 2021 - 2033 (USD Million)
8.6. Hybrid
8.6.1. Hybrid market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 9. AI in Breast Imaging Market: Regional Estimates & Trend Analysis by Imaging Modality, Application, Clinical Use, End Use, Deployment
9.1. Regional Dashboard
9.2. Market Size and Trend Analysis, 2021 to 2033
9.3. North America
9.3.1. North America AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.3.2. U.S.
9.3.2.1. Key country dynamics
9.3.2.2. Competitive scenario
9.3.2.3. Regulatory framework
9.3.2.4. Reimbursement scenario
9.3.2.5. U.S. AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.3.3. Canada
9.3.3.1. Key country dynamics
9.3.3.2. Competitive scenario
9.3.3.3. Regulatory framework
9.3.3.4. Reimbursement scenario
9.3.3.5. Canada AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.3.4. Mexico
9.3.4.1. Key country dynamics
9.3.4.2. Competitive scenario
9.3.4.3. Regulatory framework
9.3.4.4. Reimbursement scenario
9.3.4.5. Mexico AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.4. Europe
9.4.1. Europe AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.4.2. UK
9.4.2.1. Key country dynamics
9.4.2.2. Competitive scenario
9.4.2.3. Regulatory framework
9.4.2.4. Reimbursement scenario
9.4.2.5. UK AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.4.3. Germany
9.4.3.1. Key country dynamics
9.4.3.2. Competitive scenario
9.4.3.3. Regulatory framework
9.4.3.4. Reimbursement scenario
9.4.3.5. Germany AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.4.4. France
9.4.4.1. Key country dynamics
9.4.4.2. Competitive scenario
9.4.4.3. Regulatory framework
9.4.4.4. Reimbursement scenario
9.4.4.5. France AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.4.5. Italy
9.4.5.1. Key country dynamics
9.4.5.2. Competitive scenario
9.4.5.3. Regulatory framework
9.4.5.4. Reimbursement scenario
9.4.5.5. Italy AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.4.6. Spain
9.4.6.1. Key country dynamics
9.4.6.2. Competitive scenario
9.4.6.3. Regulatory framework
9.4.6.4. Reimbursement scenario
9.4.6.5. Spain AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.4.7. Sweden
9.4.7.1. Key country dynamics
9.4.7.2. Competitive scenario
9.4.7.3. Regulatory framework
9.4.7.4. Reimbursement scenario
9.4.7.5. Sweden AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.4.8. Denmark
9.4.8.1. Key country dynamics
9.4.8.2. Competitive scenario
9.4.8.3. Regulatory framework
9.4.8.4. Reimbursement scenario
9.4.8.5. Denmark AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.4.9. Norway
9.4.9.1. Key country dynamics
9.4.9.2. Competitive scenario
9.4.9.3. Regulatory framework
9.4.9.4. Reimbursement scenario
9.4.9.5. Norway AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.5. Asia Pacific
9.5.1. Asia Pacific AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.5.2. China
9.5.2.1. Key country dynamics
9.5.2.2. Competitive scenario
9.5.2.3. Regulatory framework
9.5.2.4. Reimbursement scenario
9.5.2.5. China AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.5.3. Japan
9.5.3.1. Key country dynamics
9.5.3.2. Competitive scenario
9.5.3.3. Regulatory framework
9.5.3.4. Reimbursement scenario
9.5.3.5. Japan AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.5.4. India
9.5.4.1. Key country dynamics
9.5.4.2. Competitive scenario
9.5.4.3. Regulatory framework
9.5.4.4. Reimbursement scenario
9.5.4.5. India AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.5.5. South Korea
9.5.5.1. Key country dynamics
9.5.5.2. Competitive scenario
9.5.5.3. Regulatory framework
9.5.5.4. Reimbursement scenario
9.5.5.5. South Korea AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.5.6. Australia
9.5.6.1. Key country dynamics
9.5.6.2. Competitive scenario
9.5.6.3. Regulatory framework
9.5.6.4. Reimbursement scenario
9.5.6.5. Australia AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.5.7. Thailand
9.5.7.1. Key country dynamics
9.5.7.2. Competitive scenario
9.5.7.3. Regulatory framework
9.5.7.4. Reimbursement scenario
9.5.7.5. Thailand AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.6. Latin America
9.6.1. Latin America AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.6.2. Brazil
9.6.2.1. Key country dynamics
9.6.2.2. Competitive scenario
9.6.2.3. Regulatory framework
9.6.2.4. Reimbursement scenario
9.6.2.5. Brazil AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.6.3. Argentina
9.6.3.1. Key country dynamics
9.6.3.2. Competitive scenario
9.6.3.3. Regulatory framework
9.6.3.4. Reimbursement scenario
9.6.3.5. Argentina AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.7. Middle East and Africa
9.7.1. Middle East and Africa AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.7.2. South Africa
9.7.2.1. Key country dynamics
9.7.2.2. Competitive scenario
9.7.2.3. Regulatory framework
9.7.2.4. Reimbursement scenario
9.7.2.5. South Africa AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.7.3. Saudi Arabia
9.7.3.1. Key country dynamics
9.7.3.2. Competitive scenario
9.7.3.3. Regulatory framework
9.7.3.4. Reimbursement scenario
9.7.3.5. Saudi Arabia AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.7.4. UAE
9.7.4.1. Key country dynamics
9.7.4.2. Competitive scenario
9.7.4.3. Regulatory framework
9.7.4.4. Reimbursement scenario
9.7.4.5. UAE AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.7.5. Kuwait
9.7.5.1. Key country dynamics
9.7.5.2. Competitive scenario
9.7.5.3. Regulatory framework
9.7.5.4. Reimbursement scenario
9.7.5.5. Kuwait AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.2. Market Size and Trend Analysis, 2021 to 2033
9.3. North America
9.3.1. North America AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.3.2. U.S.
9.3.2.1. Key country dynamics
9.3.2.2. Competitive scenario
9.3.2.3. Regulatory framework
9.3.2.4. Reimbursement scenario
9.3.2.5. U.S. AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.3.3. Canada
9.3.3.1. Key country dynamics
9.3.3.2. Competitive scenario
9.3.3.3. Regulatory framework
9.3.3.4. Reimbursement scenario
9.3.3.5. Canada AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.3.4. Mexico
9.3.4.1. Key country dynamics
9.3.4.2. Competitive scenario
9.3.4.3. Regulatory framework
9.3.4.4. Reimbursement scenario
9.3.4.5. Mexico AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.4. Europe
9.4.1. Europe AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.4.2. UK
9.4.2.1. Key country dynamics
9.4.2.2. Competitive scenario
9.4.2.3. Regulatory framework
9.4.2.4. Reimbursement scenario
9.4.2.5. UK AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.4.3. Germany
9.4.3.1. Key country dynamics
9.4.3.2. Competitive scenario
9.4.3.3. Regulatory framework
9.4.3.4. Reimbursement scenario
9.4.3.5. Germany AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.4.4. France
9.4.4.1. Key country dynamics
9.4.4.2. Competitive scenario
9.4.4.3. Regulatory framework
9.4.4.4. Reimbursement scenario
9.4.4.5. France AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.4.5. Italy
9.4.5.1. Key country dynamics
9.4.5.2. Competitive scenario
9.4.5.3. Regulatory framework
9.4.5.4. Reimbursement scenario
9.4.5.5. Italy AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.4.6. Spain
9.4.6.1. Key country dynamics
9.4.6.2. Competitive scenario
9.4.6.3. Regulatory framework
9.4.6.4. Reimbursement scenario
9.4.6.5. Spain AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.4.7. Sweden
9.4.7.1. Key country dynamics
9.4.7.2. Competitive scenario
9.4.7.3. Regulatory framework
9.4.7.4. Reimbursement scenario
9.4.7.5. Sweden AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.4.8. Denmark
9.4.8.1. Key country dynamics
9.4.8.2. Competitive scenario
9.4.8.3. Regulatory framework
9.4.8.4. Reimbursement scenario
9.4.8.5. Denmark AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.4.9. Norway
9.4.9.1. Key country dynamics
9.4.9.2. Competitive scenario
9.4.9.3. Regulatory framework
9.4.9.4. Reimbursement scenario
9.4.9.5. Norway AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.5. Asia Pacific
9.5.1. Asia Pacific AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.5.2. China
9.5.2.1. Key country dynamics
9.5.2.2. Competitive scenario
9.5.2.3. Regulatory framework
9.5.2.4. Reimbursement scenario
9.5.2.5. China AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.5.3. Japan
9.5.3.1. Key country dynamics
9.5.3.2. Competitive scenario
9.5.3.3. Regulatory framework
9.5.3.4. Reimbursement scenario
9.5.3.5. Japan AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.5.4. India
9.5.4.1. Key country dynamics
9.5.4.2. Competitive scenario
9.5.4.3. Regulatory framework
9.5.4.4. Reimbursement scenario
9.5.4.5. India AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.5.5. South Korea
9.5.5.1. Key country dynamics
9.5.5.2. Competitive scenario
9.5.5.3. Regulatory framework
9.5.5.4. Reimbursement scenario
9.5.5.5. South Korea AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.5.6. Australia
9.5.6.1. Key country dynamics
9.5.6.2. Competitive scenario
9.5.6.3. Regulatory framework
9.5.6.4. Reimbursement scenario
9.5.6.5. Australia AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.5.7. Thailand
9.5.7.1. Key country dynamics
9.5.7.2. Competitive scenario
9.5.7.3. Regulatory framework
9.5.7.4. Reimbursement scenario
9.5.7.5. Thailand AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.6. Latin America
9.6.1. Latin America AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.6.2. Brazil
9.6.2.1. Key country dynamics
9.6.2.2. Competitive scenario
9.6.2.3. Regulatory framework
9.6.2.4. Reimbursement scenario
9.6.2.5. Brazil AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.6.3. Argentina
9.6.3.1. Key country dynamics
9.6.3.2. Competitive scenario
9.6.3.3. Regulatory framework
9.6.3.4. Reimbursement scenario
9.6.3.5. Argentina AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.7. Middle East and Africa
9.7.1. Middle East and Africa AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.7.2. South Africa
9.7.2.1. Key country dynamics
9.7.2.2. Competitive scenario
9.7.2.3. Regulatory framework
9.7.2.4. Reimbursement scenario
9.7.2.5. South Africa AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.7.3. Saudi Arabia
9.7.3.1. Key country dynamics
9.7.3.2. Competitive scenario
9.7.3.3. Regulatory framework
9.7.3.4. Reimbursement scenario
9.7.3.5. Saudi Arabia AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.7.4. UAE
9.7.4.1. Key country dynamics
9.7.4.2. Competitive scenario
9.7.4.3. Regulatory framework
9.7.4.4. Reimbursement scenario
9.7.4.5. UAE AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
9.7.5. Kuwait
9.7.5.1. Key country dynamics
9.7.5.2. Competitive scenario
9.7.5.3. Regulatory framework
9.7.5.4. Reimbursement scenario
9.7.5.5. Kuwait AI in breast imaging market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis by Key Market Participants
10.2. Company Categorization
10.3. Company Market Share Analysis, 2025
10.4. Company Heat Map Analysis
10.5. Strategy Mapping
10.5.1. Expansion
10.5.2. Mergers & Acquisition
10.5.3. Partnerships & Collaborations
10.5.4. New Technology Launches
10.5.5. Research And Development
10.5.6. Company Profiles
10.5.7. Hologic
10.5.7.1. Company overview
10.5.7.2. Financial performance
10.5.7.3. Product benchmarking
10.5.7.4. Strategic initiatives
10.5.8. Lunit (incl. Volpara)
10.5.8.1. Company overview
10.5.8.2. Financial performance
10.5.8.3. Product benchmarking
10.5.8.4. Strategic initiatives
10.5.9. ScreenPoint Medical
10.5.9.1. Company overview
10.5.9.2. Financial performance
10.5.9.3. Product benchmarking
10.5.9.4. Strategic initiatives
10.5.10. DeepHealth (RadNet)
10.5.10.1. Company overview
10.5.10.2. Financial performance
10.5.10.3. Product benchmarking
10.5.10.4. Strategic initiatives
10.5.11. Therapixel
10.5.11.1. Company overview
10.5.11.2. Financial performance
10.5.11.3. Product benchmarking
10.5.11.4. Strategic initiatives
10.5.12. Vara
10.5.12.1. Company overview
10.5.12.2. Financial performance
10.5.12.3. Product benchmarking
10.5.12.4. Strategic initiatives
10.5.13. Siemens Healthineers
10.5.13.1. Company overview
10.5.13.2. Financial performance
10.5.13.3. Product benchmarking
10.5.13.4. Strategic initiatives
10.5.14. GE HealthCare
10.5.14.1. Company overview
10.5.14.2. Financial performance
10.5.14.3. Product benchmarking
10.5.14.4. Strategic initiatives
10.5.15. Clairity
10.5.15.1. Company overview
10.5.15.2. Financial performance
10.5.15.3. Product benchmarking
10.5.15.4. Strategic initiatives
10.5.16. Koios Medical
10.5.16.1. Company overview
10.5.16.2. Financial performance
10.5.16.3. Product benchmarking
10.5.16.4. Strategic initiatives
10.5.17. CureMetrix
10.5.17.1. Company overview
10.5.17.2. Financial performance
10.5.17.3. Product benchmarking
10.5.17.4. Strategic initiatives
10.5.18. Densitas
10.5.18.1. Company overview
10.5.18.2. Financial performance
10.5.18.3. Product benchmarking
10.5.18.4. Strategic initiatives
10.5.19. Whiterabbit.ai
10.5.19.1. Company overview
10.5.19.2. Financial performance
10.5.19.3. Product benchmarking
10.5.19.4. Strategic initiatives
10.5.20. MedCognetics
10.5.20.1. Company overview
10.5.20.2. Financial performance
10.5.20.3. Product benchmarking
10.5.20.4. Strategic initiatives
10.5.21. Philips
10.5.21.1. Company overview
10.5.21.2. Financial performance
10.5.21.3. Product benchmarking
10.5.21.4. Strategic initiatives
10.5.22. Quibim
10.5.22.1. Company overview
10.5.22.2. Financial performance
10.5.22.3. Product benchmarking
10.5.22.4. Strategic initiatives
10.5.23. QView Medical
10.5.23.1. Company overview
10.5.23.2. Financial performance
10.5.23.3. Product benchmarking
10.5.23.4. Strategic initiatives
10.5.24. Qlarity Imaging
10.5.24.1. Company overview
10.5.24.2. Financial performance
10.5.24.3. Product benchmarking
10.5.24.4. Strategic initiatives
10.2. Company Categorization
10.3. Company Market Share Analysis, 2025
10.4. Company Heat Map Analysis
10.5. Strategy Mapping
10.5.1. Expansion
10.5.2. Mergers & Acquisition
10.5.3. Partnerships & Collaborations
10.5.4. New Technology Launches
10.5.5. Research And Development
10.5.6. Company Profiles
10.5.7. Hologic
10.5.7.1. Company overview
10.5.7.2. Financial performance
10.5.7.3. Product benchmarking
10.5.7.4. Strategic initiatives
10.5.8. Lunit (incl. Volpara)
10.5.8.1. Company overview
10.5.8.2. Financial performance
10.5.8.3. Product benchmarking
10.5.8.4. Strategic initiatives
10.5.9. ScreenPoint Medical
10.5.9.1. Company overview
10.5.9.2. Financial performance
10.5.9.3. Product benchmarking
10.5.9.4. Strategic initiatives
10.5.10. DeepHealth (RadNet)
10.5.10.1. Company overview
10.5.10.2. Financial performance
10.5.10.3. Product benchmarking
10.5.10.4. Strategic initiatives
10.5.11. Therapixel
10.5.11.1. Company overview
10.5.11.2. Financial performance
10.5.11.3. Product benchmarking
10.5.11.4. Strategic initiatives
10.5.12. Vara
10.5.12.1. Company overview
10.5.12.2. Financial performance
10.5.12.3. Product benchmarking
10.5.12.4. Strategic initiatives
10.5.13. Siemens Healthineers
10.5.13.1. Company overview
10.5.13.2. Financial performance
10.5.13.3. Product benchmarking
10.5.13.4. Strategic initiatives
10.5.14. GE HealthCare
10.5.14.1. Company overview
10.5.14.2. Financial performance
10.5.14.3. Product benchmarking
10.5.14.4. Strategic initiatives
10.5.15. Clairity
10.5.15.1. Company overview
10.5.15.2. Financial performance
10.5.15.3. Product benchmarking
10.5.15.4. Strategic initiatives
10.5.16. Koios Medical
10.5.16.1. Company overview
10.5.16.2. Financial performance
10.5.16.3. Product benchmarking
10.5.16.4. Strategic initiatives
10.5.17. CureMetrix
10.5.17.1. Company overview
10.5.17.2. Financial performance
10.5.17.3. Product benchmarking
10.5.17.4. Strategic initiatives
10.5.18. Densitas
10.5.18.1. Company overview
10.5.18.2. Financial performance
10.5.18.3. Product benchmarking
10.5.18.4. Strategic initiatives
10.5.19. Whiterabbit.ai
10.5.19.1. Company overview
10.5.19.2. Financial performance
10.5.19.3. Product benchmarking
10.5.19.4. Strategic initiatives
10.5.20. MedCognetics
10.5.20.1. Company overview
10.5.20.2. Financial performance
10.5.20.3. Product benchmarking
10.5.20.4. Strategic initiatives
10.5.21. Philips
10.5.21.1. Company overview
10.5.21.2. Financial performance
10.5.21.3. Product benchmarking
10.5.21.4. Strategic initiatives
10.5.22. Quibim
10.5.22.1. Company overview
10.5.22.2. Financial performance
10.5.22.3. Product benchmarking
10.5.22.4. Strategic initiatives
10.5.23. QView Medical
10.5.23.1. Company overview
10.5.23.2. Financial performance
10.5.23.3. Product benchmarking
10.5.23.4. Strategic initiatives
10.5.24. Qlarity Imaging
10.5.24.1. Company overview
10.5.24.2. Financial performance
10.5.24.3. Product benchmarking
10.5.24.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 3 North America AI in breast imaging market, application, (USD Million) 2021-2033
Table 4 North America AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 5 North America AI in breast imaging market, end use, (USD Million) 2021-2033
Table 6 North America AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 7 U.S. AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 8 U.S. AI in breast imaging market, application, (USD Million) 2021-2033
Table 9 U.S. AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 10 U.S. AI in breast imaging market, end use, (USD Million) 2021-2033
Table 11 U.S. AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 12 Canada AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 13 Canada AI in breast imaging market, application, (USD Million) 2021-2033
Table 14 Canada AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 15 Canada AI in breast imaging market, end use, (USD Million) 2021-2033
Table 16 Canada AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 17 Mexico AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 18 Mexico AI in breast imaging market, application, (USD Million) 2021-2033
Table 19 Mexico AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 20 Mexico AI in breast imaging market, end use, (USD Million) 2021-2033
Table 21 Mexico AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 22 Europe AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 23 Europe AI in breast imaging market, application, (USD Million) 2021-2033
Table 24 Europe AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 25 Europe AI in breast imaging market, end use, (USD Million) 2021-2033
Table 26 Europe AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 27 Germany AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 28 Germany AI in breast imaging market, application, (USD Million) 2021-2033
Table 29 Germany AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 30 Germany AI in breast imaging market, end use, (USD Million) 2021-2033
Table 31 Germany AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 32 UK AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 33 UK AI in breast imaging market, application, (USD Million) 2021-2033
Table 34 UK AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 35 UK AI in breast imaging market, end use, (USD Million) 2021-2033
Table 36 UK AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 37 France AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 38 France AI in breast imaging market, application, (USD Million) 2021-2033
Table 39 France AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 40 France AI in breast imaging market, end use, (USD Million) 2021-2033
Table 41 France AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 42 Italy AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 43 Italy AI in breast imaging market, application, (USD Million) 2021-2033
Table 44 Italy AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 45 Italy AI in breast imaging market, end use, (USD Million) 2021-2033
Table 46 Italy AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 47 Spain AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 48 Spain AI in breast imaging market, application, (USD Million) 2021-2033
Table 49 Spain AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 50 Spain AI in breast imaging market, end use, (USD Million) 2021-2033
Table 51 Spain AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 52 Denmark AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 53 Denmark AI in breast imaging market, application, (USD Million) 2021-2033
Table 54 Denmark AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 55 Denmark AI in breast imaging market, end use, (USD Million) 2021-2033
Table 56 Denmark AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 57 Sweden AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 58 Sweden AI in breast imaging market, application, (USD Million) 2021-2033
Table 59 Sweden AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 60 Sweden AI in breast imaging market, end use, (USD Million) 2021-2033
Table 61 Sweden AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 62 Norway AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 63 Norway AI in breast imaging market, application, (USD Million) 2021-2033
Table 64 Norway AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 65 Norway AI in breast imaging market, end use, (USD Million) 2021-2033
Table 66 Norway AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 67 Asia Pacific AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 68 Asia Pacific AI in breast imaging market, application, (USD Million) 2021-2033
Table 69 Asia Pacific AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 70 Asia Pacific AI in breast imaging market, end use, (USD Million) 2021-2033
Table 71 Asia Pacific AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 72 China AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 73 China AI in breast imaging market, application, (USD Million) 2021-2033
Table 74 China AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 75 China AI in breast imaging market, end use, (USD Million) 2021-2033
Table 76 China AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 77 India AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 78 India AI in breast imaging market, application, (USD Million) 2021-2033
Table 79 India AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 80 India AI in breast imaging market, end use, (USD Million) 2021-2033
Table 81 India AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 82 Japan AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 83 Japan AI in breast imaging market, application, (USD Million) 2021-2033
Table 84 Japan AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 85 Japan AI in breast imaging market, end use, (USD Million) 2021-2033
Table 86 Japan AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 87 Australia AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 88 Australia AI in breast imaging market, application, (USD Million) 2021-2033
Table 89 Australia AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 90 Australia AI in breast imaging market, end use, (USD Million) 2021-2033
Table 91 Australia AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 92 South Korea AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 93 South Korea AI in breast imaging market, application, (USD Million) 2021-2033
Table 94 South Korea AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 95 South Korea AI in breast imaging market, end use, (USD Million) 2021-2033
Table 96 South Korea AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 97 Thailand AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 98 Thailand AI in breast imaging market, application, (USD Million) 2021-2033
Table 99 Thailand AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 100 Thailand AI in breast imaging market, end use, (USD Million) 2021-2033
Table 101 Thailand AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 102 Latin America AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 103 Latin America AI in breast imaging market, application, (USD Million) 2021-2033
Table 104 Latin America AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 105 Latin America AI in breast imaging market, end use, (USD Million) 2021-2033
Table 106 Latin America AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 107 Brazil AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 108 Brazil AI in breast imaging market, application, (USD Million) 2021-2033
Table 109 Brazil AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 110 Brazil AI in breast imaging market, end use, (USD Million) 2021-2033
Table 111 Brazil AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 112 Argentina AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 113 Argentina AI in breast imaging market, application, (USD Million) 2021-2033
Table 114 Argentina AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 115 Argentina AI in breast imaging market, end use, (USD Million) 2021-2033
Table 116 Argentina AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 117 MEA AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 118 MEA AI in breast imaging market, application, (USD Million) 2021-2033
Table 119 MEA AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 120 MEA AI in breast imaging market, end use, (USD Million) 2021-2033
Table 121 MEA AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 122 South Africa AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 123 South Africa AI in breast imaging market, application, (USD Million) 2021-2033
Table 124 South Africa AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 125 South Africa AI in breast imaging market, end use, (USD Million) 2021-2033
Table 126 South Africa AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 127 Saudi Arabia AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 128 Saudi Arabia AI in breast imaging market, application, (USD Million) 2021-2033
Table 129 Saudi Arabia AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 130 Saudi Arabia AI in breast imaging market, end use, (USD Million) 2021-2033
Table 131 Saudi Arabia AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 132 UAE AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 133 UAE AI in breast imaging market, application, (USD Million) 2021-2033
Table 134 UAE AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 135 UAE AI in breast imaging market, end use, (USD Million) 2021-2033
Table 136 UAE AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 137 Kuwait AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 138 Kuwait AI in breast imaging market, application, (USD Million) 2021-2033
Table 139 Kuwait AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 140 Kuwait AI in breast imaging market, end use, (USD Million) 2021-2033
Table 141 Kuwait AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 2 North America AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 3 North America AI in breast imaging market, application, (USD Million) 2021-2033
Table 4 North America AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 5 North America AI in breast imaging market, end use, (USD Million) 2021-2033
Table 6 North America AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 7 U.S. AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 8 U.S. AI in breast imaging market, application, (USD Million) 2021-2033
Table 9 U.S. AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 10 U.S. AI in breast imaging market, end use, (USD Million) 2021-2033
Table 11 U.S. AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 12 Canada AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 13 Canada AI in breast imaging market, application, (USD Million) 2021-2033
Table 14 Canada AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 15 Canada AI in breast imaging market, end use, (USD Million) 2021-2033
Table 16 Canada AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 17 Mexico AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 18 Mexico AI in breast imaging market, application, (USD Million) 2021-2033
Table 19 Mexico AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 20 Mexico AI in breast imaging market, end use, (USD Million) 2021-2033
Table 21 Mexico AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 22 Europe AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 23 Europe AI in breast imaging market, application, (USD Million) 2021-2033
Table 24 Europe AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 25 Europe AI in breast imaging market, end use, (USD Million) 2021-2033
Table 26 Europe AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 27 Germany AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 28 Germany AI in breast imaging market, application, (USD Million) 2021-2033
Table 29 Germany AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 30 Germany AI in breast imaging market, end use, (USD Million) 2021-2033
Table 31 Germany AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 32 UK AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 33 UK AI in breast imaging market, application, (USD Million) 2021-2033
Table 34 UK AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 35 UK AI in breast imaging market, end use, (USD Million) 2021-2033
Table 36 UK AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 37 France AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 38 France AI in breast imaging market, application, (USD Million) 2021-2033
Table 39 France AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 40 France AI in breast imaging market, end use, (USD Million) 2021-2033
Table 41 France AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 42 Italy AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 43 Italy AI in breast imaging market, application, (USD Million) 2021-2033
Table 44 Italy AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 45 Italy AI in breast imaging market, end use, (USD Million) 2021-2033
Table 46 Italy AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 47 Spain AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 48 Spain AI in breast imaging market, application, (USD Million) 2021-2033
Table 49 Spain AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 50 Spain AI in breast imaging market, end use, (USD Million) 2021-2033
Table 51 Spain AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 52 Denmark AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 53 Denmark AI in breast imaging market, application, (USD Million) 2021-2033
Table 54 Denmark AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 55 Denmark AI in breast imaging market, end use, (USD Million) 2021-2033
Table 56 Denmark AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 57 Sweden AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 58 Sweden AI in breast imaging market, application, (USD Million) 2021-2033
Table 59 Sweden AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 60 Sweden AI in breast imaging market, end use, (USD Million) 2021-2033
Table 61 Sweden AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 62 Norway AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 63 Norway AI in breast imaging market, application, (USD Million) 2021-2033
Table 64 Norway AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 65 Norway AI in breast imaging market, end use, (USD Million) 2021-2033
Table 66 Norway AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 67 Asia Pacific AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 68 Asia Pacific AI in breast imaging market, application, (USD Million) 2021-2033
Table 69 Asia Pacific AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 70 Asia Pacific AI in breast imaging market, end use, (USD Million) 2021-2033
Table 71 Asia Pacific AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 72 China AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 73 China AI in breast imaging market, application, (USD Million) 2021-2033
Table 74 China AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 75 China AI in breast imaging market, end use, (USD Million) 2021-2033
Table 76 China AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 77 India AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 78 India AI in breast imaging market, application, (USD Million) 2021-2033
Table 79 India AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 80 India AI in breast imaging market, end use, (USD Million) 2021-2033
Table 81 India AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 82 Japan AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 83 Japan AI in breast imaging market, application, (USD Million) 2021-2033
Table 84 Japan AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 85 Japan AI in breast imaging market, end use, (USD Million) 2021-2033
Table 86 Japan AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 87 Australia AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 88 Australia AI in breast imaging market, application, (USD Million) 2021-2033
Table 89 Australia AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 90 Australia AI in breast imaging market, end use, (USD Million) 2021-2033
Table 91 Australia AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 92 South Korea AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 93 South Korea AI in breast imaging market, application, (USD Million) 2021-2033
Table 94 South Korea AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 95 South Korea AI in breast imaging market, end use, (USD Million) 2021-2033
Table 96 South Korea AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 97 Thailand AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 98 Thailand AI in breast imaging market, application, (USD Million) 2021-2033
Table 99 Thailand AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 100 Thailand AI in breast imaging market, end use, (USD Million) 2021-2033
Table 101 Thailand AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 102 Latin America AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 103 Latin America AI in breast imaging market, application, (USD Million) 2021-2033
Table 104 Latin America AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 105 Latin America AI in breast imaging market, end use, (USD Million) 2021-2033
Table 106 Latin America AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 107 Brazil AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 108 Brazil AI in breast imaging market, application, (USD Million) 2021-2033
Table 109 Brazil AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 110 Brazil AI in breast imaging market, end use, (USD Million) 2021-2033
Table 111 Brazil AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 112 Argentina AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 113 Argentina AI in breast imaging market, application, (USD Million) 2021-2033
Table 114 Argentina AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 115 Argentina AI in breast imaging market, end use, (USD Million) 2021-2033
Table 116 Argentina AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 117 MEA AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 118 MEA AI in breast imaging market, application, (USD Million) 2021-2033
Table 119 MEA AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 120 MEA AI in breast imaging market, end use, (USD Million) 2021-2033
Table 121 MEA AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 122 South Africa AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 123 South Africa AI in breast imaging market, application, (USD Million) 2021-2033
Table 124 South Africa AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 125 South Africa AI in breast imaging market, end use, (USD Million) 2021-2033
Table 126 South Africa AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 127 Saudi Arabia AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 128 Saudi Arabia AI in breast imaging market, application, (USD Million) 2021-2033
Table 129 Saudi Arabia AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 130 Saudi Arabia AI in breast imaging market, end use, (USD Million) 2021-2033
Table 131 Saudi Arabia AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 132 UAE AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 133 UAE AI in breast imaging market, application, (USD Million) 2021-2033
Table 134 UAE AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 135 UAE AI in breast imaging market, end use, (USD Million) 2021-2033
Table 136 UAE AI in breast imaging market, deployment, (USD Million) 2021-2033
Table 137 Kuwait AI in breast imaging market, imaging modality, (USD Million) 2021-2033
Table 138 Kuwait AI in breast imaging market, application, (USD Million) 2021-2033
Table 139 Kuwait AI in breast imaging market, clinical use, (USD Million) 2021-2033
Table 140 Kuwait AI in breast imaging market, end use, (USD Million) 2021-2033
Table 141 Kuwait AI in breast imaging market, deployment, (USD Million) 2021-2033
List of Figures
Figure 1 AI in breast imaging market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Data analysis models
Figure 5 Market formulation and validation
Figure 6 Data validating & publishing
Figure 7 Market snapshot
Figure 8 Segment snapshot
Figure 9 Competitive landscape snapshot
Figure 10 AI in breast imaging market size and growth prospects (USD Million)
Figure 11 AI in breast imaging market: Industry value chain analysis
Figure 12 AI in breast imaging market: Market dynamics
Figure 13 AI in breast imaging market: PORTER's analysis
Figure 14 AI in breast imaging market: PESTEL analysis
Figure 15 AI in breast imaging market share by imaging modality, 2025 & 2033 (USD Million)
Figure 16 AI in breast imaging market, imaging modality: market share, 2025 & 2033
Figure 17 Mammography market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 18 2D Digital mammography market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 19 Digital breast tomosynthesis market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 20 Contrast-enhanced mammography market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 21 Breast ultrasound market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 22 Handheld ultrasound market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 23 Automated whole-breast ultrasound market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 24 Breast MRI market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 25 Conventional contrast-enhanced MRI market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 26 Abbreviated breast MRI market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 27 Other imaging modalities market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 28 AI in breast imaging market share by application, 2025 & 2033 (USD Million)
Figure 29 AI in breast imaging market, application: market share, 2025 & 2033
Figure 30 Cancer detection and localization market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 31 Lesion characterization and diagnostic support market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 32 Breast density assessment market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 33 Image-based risk prediction market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 34 Image acquisition and reconstruction market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 35 Workflow, reporting, and quality assurance market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 36 Treatment response assessment market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 37 AI in breast imaging market share by clinical use, 2025 & 2033 (USD Million)
Figure 38 AI in breast imaging market, clinical use: market share, 2025 & 2033
Figure 39 Routine screening market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 40 Supplemental and high-risk screening market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 41 Diagnostic evaluation market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 42 Staging and treatment monitoring market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 43 AI in breast imaging market share by end use, 2025 & 2033 (USD Million)
Figure 44 AI in breast imaging market, end use: market share, 2025 & 2033
Figure 45 Hospitals & academic medical centers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 46 Independent breast and women’s health centers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 47 Independent diagnostic imaging centers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 48 Government & public health screening programs market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 49 AI in breast imaging market share by deployment, 2025 & 2033 (USD Million)
Figure 50 AI in breast imaging market, deployment: market share, 2025 & 2033
Figure 51 On-premises market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 52 Cloud-based market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 53 Hybrid market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 54 Regional marketplace: key takeaways
Figure 55 North America AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 56 U.S. AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 57 Canada AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 58 Mexico AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 59 Europe AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 60 UK AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 61 Germany AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 62 France AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 63 Italy AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 64 Spain AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 65 Sweden AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 66 Denmark AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 67 Norway AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 68 Asia Pacific AI in breast imaging market estimates and forecast, 2021 - 2033, (USD Million)
Figure 69 China AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 70 Japan AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 71 India AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 72 South Korea AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 73 Australia AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 74 Thailand AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 75 Latin America AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 76 Brazil AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 77 Argentina AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 78 MEA AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 79 South Africa AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 80 Saudi Arabia AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 81 UAE AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 82 Kuwait AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 83 Key company categorization
Figure 84 Company market positioning
Figure 85 Key company market share analysis, 2025
Figure 86 Strategic framework
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Data analysis models
Figure 5 Market formulation and validation
Figure 6 Data validating & publishing
Figure 7 Market snapshot
Figure 8 Segment snapshot
Figure 9 Competitive landscape snapshot
Figure 10 AI in breast imaging market size and growth prospects (USD Million)
Figure 11 AI in breast imaging market: Industry value chain analysis
Figure 12 AI in breast imaging market: Market dynamics
Figure 13 AI in breast imaging market: PORTER's analysis
Figure 14 AI in breast imaging market: PESTEL analysis
Figure 15 AI in breast imaging market share by imaging modality, 2025 & 2033 (USD Million)
Figure 16 AI in breast imaging market, imaging modality: market share, 2025 & 2033
Figure 17 Mammography market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 18 2D Digital mammography market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 19 Digital breast tomosynthesis market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 20 Contrast-enhanced mammography market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 21 Breast ultrasound market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 22 Handheld ultrasound market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 23 Automated whole-breast ultrasound market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 24 Breast MRI market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 25 Conventional contrast-enhanced MRI market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 26 Abbreviated breast MRI market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 27 Other imaging modalities market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 28 AI in breast imaging market share by application, 2025 & 2033 (USD Million)
Figure 29 AI in breast imaging market, application: market share, 2025 & 2033
Figure 30 Cancer detection and localization market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 31 Lesion characterization and diagnostic support market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 32 Breast density assessment market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 33 Image-based risk prediction market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 34 Image acquisition and reconstruction market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 35 Workflow, reporting, and quality assurance market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 36 Treatment response assessment market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 37 AI in breast imaging market share by clinical use, 2025 & 2033 (USD Million)
Figure 38 AI in breast imaging market, clinical use: market share, 2025 & 2033
Figure 39 Routine screening market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 40 Supplemental and high-risk screening market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 41 Diagnostic evaluation market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 42 Staging and treatment monitoring market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 43 AI in breast imaging market share by end use, 2025 & 2033 (USD Million)
Figure 44 AI in breast imaging market, end use: market share, 2025 & 2033
Figure 45 Hospitals & academic medical centers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 46 Independent breast and women’s health centers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 47 Independent diagnostic imaging centers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 48 Government & public health screening programs market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 49 AI in breast imaging market share by deployment, 2025 & 2033 (USD Million)
Figure 50 AI in breast imaging market, deployment: market share, 2025 & 2033
Figure 51 On-premises market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 52 Cloud-based market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 53 Hybrid market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 54 Regional marketplace: key takeaways
Figure 55 North America AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 56 U.S. AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 57 Canada AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 58 Mexico AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 59 Europe AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 60 UK AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 61 Germany AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 62 France AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 63 Italy AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 64 Spain AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 65 Sweden AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 66 Denmark AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 67 Norway AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 68 Asia Pacific AI in breast imaging market estimates and forecast, 2021 - 2033, (USD Million)
Figure 69 China AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 70 Japan AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 71 India AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 72 South Korea AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 73 Australia AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 74 Thailand AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 75 Latin America AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 76 Brazil AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 77 Argentina AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 78 MEA AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 79 South Africa AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 80 Saudi Arabia AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 81 UAE AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 82 Kuwait AI in breast imaging market estimates and forecasts, 2021 - 2033, (USD Million)
Figure 83 Key company categorization
Figure 84 Company market positioning
Figure 85 Key company market share analysis, 2025
Figure 86 Strategic framework
Companies Mentioned
- Hologic
- Lunit (incl. Volpara)
- ScreenPoint Medical
- DeepHealth (RadNet)
- Therapixel
- Vara
- Siemens Healthineers
- GE HealthCare
- Clairity
- Koios Medical
- CureMetrix
- Densitas
- Whiterabbit.ai
- MedCognetics
- Philips
- Quibim
- QView Medical
- Qlarity Imaging

